Enabling Meaningful Metabolic Disease Research

Clear efficacy signals are as crucial as keeping research representative and reasonable in this complex field. Worldwide delivers studies that make sense for everyone


Whether your indication has millions of potential participants across the globe or just dozens, know that Worldwide’s dedicated team and global network of trusted partner sites can offer the expertise you need to succeed. Our extensive group of subject matter experts in both rare and common metabolic conditions help get studies done right. 



Scott’s experience includes project management, clinical team management, portfolio development, and training across all phases of development, including compassionate use programs. He has more than 24 years of experience in the industry, with extensive NASH/NAFLD experience in Phase II and several Phase III programs. His proven leadership and strategic protocol and operational expertise ensure successful implementation and delivery for his projects.

Human capital that brings clarity to complexity 

At Worldwide, we understand that our greatest strength is our personnel—our expert teams around the world that craft unparalleled design and logistics solutions for even the most challenging studies. When you start with a better CRO team, you get a better study experience for the life of your program.

Metabolic Experience

  • Common Disorders
  • Chronic Kidney Disease
  • Diabetes Type 1/Juvenile
  • Diabetes Type 2
  • Dyslipidemia
  • Kidney Disease
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Non-Alcoholic Steatohepatitis (NASH)
  • Obesity
  • Rare Endocrine and Metabolic Disorders
  • Adrenal Insufficiency
  • Congenital Adrenal Hyperplasia
  • Fabry Disease
  • Familial Chylomicronemia Syndrome
  • Fatty Acid Biosynthesis Disorders
  • Growth Hormone Deficiency
  • Homozygous Familial Hypercholesterolemia
  • Lysosomal Storage Disorder
  • Mucopolysaccharidosis
  • Niemann-Pick Disease
  • Phenylketonuria
  • Tyrosinemia

Our Dedicated Team